We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Potential Diabetes Drug Works by Relieving Endoplasmic Reticulum Stress

By LabMedica International staff writers
Posted on 30 Jun 2015
Print article
Image: Three dimensional rendering of the endoplasmic reticulum (Photo courtesy of Blausen Gallery 2014 via Wikimedia Commons).
Image: Three dimensional rendering of the endoplasmic reticulum (Photo courtesy of Blausen Gallery 2014 via Wikimedia Commons).
A recent paper linked stress affecting the endoplasmic reticulum (ER) to the development of several chronic diseases including diabetes, retinitis pigmentosa, cystic fibrosis, Huntington's disease, and Alzheimer's disease.

The ER plays a critical role in protein, lipid, and glucose metabolism as well as cellular calcium signaling and homeostasis. Disruptions of ER function and chronic ER stress have been associated with many disease states ranging from diabetes and neurodegenerative diseases to cancer and inflammation. Although ER targeting shows therapeutic promise in preclinical models of obesity and other diseases, available drugs generally lack the specificity and other pharmacological properties required for effective clinical use.

To gain a better understanding of how the ER connects to disease development, investigators at Harvard University Medical School (Boston, MA, USA) designed and chemically and genetically validated two high-throughput functional screening systems that independently measured the free chaperone content and protein-folding capacity of the ER in living cells.

Using these screening platforms they characterized a small-molecule compound, azoramide (N-{2-[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]ethyl}butanamide), which improved ER protein-folding ability and activated ER chaperone capacity to protect cells against ER stress in multiple systems.

They further reported in the June 17, 2015, online edition of the journal Science Translational Medicine that azoramide exhibited potent anti-diabetic efficacy in two independent mouse models of obesity by improving insulin sensitivity and pancreatic beta cell function.

"While we and others had previously discovered the central role that ER stress plays in diabetes and metabolic disease, efforts to translate that knowledge into clinically effective ways to improve ER function have had limited success so far," said senior author, Dr. Gokhan S. Hotamisligil, professor of genetics and complex diseases at Harvard University Medical School. "These results show the broad potential for azoramide or drugs with similar functions targeted at the endoplasmic reticulum. ER dysfunction is implicated in many other disease processes such as cystic fibrosis, Huntington's disease, and Alzheimer's, which makes this novel screening strategy an exciting new tool that can be applied by multiple labs to discover new drug candidates for diseases that are linked to ER stress."

Related Links:

Harvard University Medical School


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.